Amplify antimicrobial photo dynamic therapy efficacy with poly-beta-amino esters (PBAEs)

Light-activated antimicrobial agents (photosensitisers) are promising alternatives to antibiotics for the treatment of skin infections and wounds through antimicrobial photo dynamic therapy (aPDT); utilisation of this technique is still restricted by general low efficacy requiring long exposure time (in the order of tens of minutes) that make the treatment very resource intensive. We report for the first time the possibility of harvesting the cell penetrating properties of poly-beta-amino esters (PBAEs) in combination with toluidine blue O (TBO) to shorten aPDT exposure time. Candidates capable of inactivation rates 30 times quicker than pure TBO were discovered and further improvements through PBAE backbone optimisation could be foreseen. Efficacy of the complexes was PBAE-dependent on a combination of TBO uptake and a newly discovered and unexpected role of PBAEs on reactive species production. Chemometric approach of partial least square regression was employed to assess the critical PBAE properties involved in this newly observed phenomenon in order to elicit a possible mechanism. The superior antimicrobial performance of this new approach benefits from the use of well established, low-cost and safe dye (TBO) coupled with inexpensive, widely tested and biodegradable polymers also known to be safe. Moreover, no adverse cytotoxic effects of the PBAEs adjuvated TBO delivery have been observed on a skin cells in vitro model demonstrating the safety profile of this new technology.

Automated summary

This study discovered the possibility of reducing exposure time of antimicrobial photo dynamic therapy (aPDT) by combining poly-beta-amino esters (PBAEs) with toluidine blue O (TBO), resulting in inactivation rates 30 times quicker and potential for further improvements through PBAE backbone optimisation. The superior antimicrobial performance of this new approach benefits from the use of well-established, low-cost and safe dye (TBO) coupled with inexpensive, widely tested and biodegradable polymers also known to be safe. Additionally, no adverse cytotoxic effects of the PBAEs adjuvated TBO delivery have been observed, demonstrating the safety profile of this new technology.